Steroid avoidance in renal transplantation using basiliximab induction, cyclosporine‐based immunosuppression and protocol biopsies

Abstract

The SA is safe in the context of basiliximab induction and CsA-based immunosuppression. This protocol could minimize steroid-related side effects in susceptible groups, including African-Americans, without increasing the risk of AR or graft failure.